Chul Soon Yong
- Pharmaceutical Science top 0.02%
- Drug Solubulity and Delivery Systems 61
- Advanced Drug Delivery Systems 55
- Advancements in Transdermal Drug Delivery 24
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery 59
- Molecular Medicine top 0.5%
- Rehabilitation top 0.5%
- Wound Healing and Treatments 15
- Biomedical Engineering top 0.5%
- Nanoplatforms for cancer theranostics 31
-
- Analytical Methods in Pharmaceuticals 22
-
- RNA Interference and Gene Delivery 18
- Co-authors
- Jong Oh KimHan‐Gon ChoiJee‐Heon JeongSae‐Kwang KuThiruganesh RamasamySung Giu JinBijay Kumar PoudelHanh Thuy Nguyen
- Partner nations
- South KoreaVietnamChina
In The Last Decade
Chul Soon Yong
232 papers receiving 10.2k citations
Peers
Comparison fields: 5 of 156
- Pharmaceutical Science 3.6k
- Biomaterials 3.1k
- Molecular Medicine 679
- Rehabilitation 567
- Biomedical Engineering 2.5k
Countries citing papers authored by Chul Soon Yong
This map shows the geographic impact of Chul Soon Yong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chul Soon Yong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chul Soon Yong more than expected).
Fields of papers citing papers by Chul Soon Yong
This network shows the impact of papers produced by Chul Soon Yong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chul Soon Yong. The network helps show where Chul Soon Yong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chul Soon Yong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 14 | |
| 2 | 2020 | 26 | |
| 3 | 2020 | 16 | |
| 4 | 2019 | 40 | |
| 5 | 2019 | 59 | |
| 6 | 2019 | 21 | |
| 7 | 2019 | 57 | |
| 8 | 2019 | 24 | |
| 9 | 2019 | 41 | |
| 10 | 2018 | 163 | |
| 11 | 2018 | 50 | |
| 12 | 2018 | 93 | |
| 13 | 2018 | 19 | |
| 14 | 2018 | 80 | |
| 15 | 2018 | 47 | |
| 16 | 2018 | 103 | |
| 17 | 2017 | 26 | |
| 18 | 2017 | 51 | |
| 19 | 2017 | 35 | |
| 20 | 2017 | 40 |
About Chul Soon Yong
Chul Soon Yong is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Medicine, having authored 232 papers that have together received 10.5k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (61 papers), Nanoparticle-Based Drug Delivery (59 papers), Advanced Drug Delivery Systems (55 papers), Nanoplatforms for cancer theranostics (31 papers), Advancements in Transdermal Drug Delivery (24 papers), Analytical Methods in Pharmaceuticals (22 papers), RNA Interference and Gene Delivery (18 papers) and Wound Healing and Treatments (15 papers). The work is most often cited by research in Pharmaceutical Science (3.6k citations), Biomaterials (3.1k citations) and Molecular Medicine (679 citations). Chul Soon Yong has collaborated with scholars based in South Korea, Vietnam and China. Frequent co-authors include Jong Oh Kim, Han‐Gon Choi, Jee‐Heon Jeong, Sae‐Kwang Ku, Thiruganesh Ramasamy, Sung Giu Jin, Bijay Kumar Poudel, Hanh Thuy Nguyen, Jong Soo Woo and Tuan Hiep Tran. Their work appears in journals such as ACS Nano, Biomaterials and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.